http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005116242-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5014 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2005-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2005116242-A1 |
titleOfInvention | Pharmaceutical safety test method and pharmaceutical safety test system |
abstract | An object of the present invention is to provide a pharmaceutical safety test method and system that is highly reliable in risk assessment of pharmaceuticals in a measurement state simulating a biological environment. The pharmaceutical safety test method of the present invention is a pharmaceutical safety test method using a cell comprising a HERG ion channel and its homologues, and using a sensor having a plurality of measurement electrodes, and A) A step of measuring the electrical response of the sensor in contact with a control solution not containing, B) a step of measuring the electrical response of the sensor in contact with a measurement solution containing the drug under test, and C) after step B1 , Again measuring the electrical response of the sensor in contact with the control solution not containing the drug under test, comparing the voltage signals measured in step A and step C, and based on the results Determine the risk of the drug under test. |
priorityDate | 2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.